2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Deferiprone: new trials by email Literature Review of Deferiprone trials Research Report on Deferiprone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias Deferiprone - Iron Overload, Sickle Cell Disease | Phase 4 | Terminated | ApoPharma | 134 | 2015-05-21 | 2024-01-10 |
| Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias Deferiprone, Deferoxamine - Iron Overload, Sickle Cell Disease | Phase 4 | Terminated | ApoPharma | 230 | 2014-04-17 | 2021-08-10 |
Anemia, Sickle Cell (2) · Iron Overload (2)
ApoPharma (2)
Canada (2) · Egypt (2) · Saudi Arabia (2) · United Kingdom (2) · United States (2) · Brazil (1) · Tunisia (1) · Turkey (Türkiye) (1)